156 related articles for article (PubMed ID: 18636307)
1. Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet's disease.
Taysi S; Sari RA; Dursun H; Yilmaz A; Keles M; Cayir K; Akyuz M; Uyanik A; Guvenc A
Clin Rheumatol; 2008 Dec; 27(12):1529-34. PubMed ID: 18636307
[TBL] [Abstract][Full Text] [Related]
2. Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.
Ozkan Y; Yardim-Akaydin S; Sepici A; Engin B; Sepici V; Simşek B
Clin Chem Lab Med; 2007; 45(1):73-7. PubMed ID: 17243919
[TBL] [Abstract][Full Text] [Related]
3. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease.
Er H; Evereklioglu C; Cumurcu T; Türköz Y; Ozerol E; Sahin K; Doganay S
Br J Ophthalmol; 2002 Jun; 86(6):653-7. PubMed ID: 12034688
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine may involve in the pathogenesis of Behcet's disease by inducing inflammation.
Kartal Durmazlar SP; Akgul A; Eskioglu F
Mediators Inflamm; 2008; 2008():407972. PubMed ID: 19197380
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet's disease.
Messedi M; Frigui M; Chaabouni Kh; Turki M; Neifer M; Lahiyani A; Messaouad M; Bahloul Z; Ayedi F; Jamoussi K
Gene; 2013 Sep; 527(1):306-10. PubMed ID: 23827456
[TBL] [Abstract][Full Text] [Related]
7. The significance of serum nitric oxide levels in Behçet's disease and recurrent aphthous stomatitis.
Yildirim M; Baysal V; Inaloz HS; Doguc D
J Dermatol; 2004 Dec; 31(12):983-8. PubMed ID: 15801262
[TBL] [Abstract][Full Text] [Related]
8. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease.
Akdeniz N; Esrefoglu M; Keleş MS; Karakuzu A; Atasoy M
Ann Acad Med Singap; 2004 Sep; 33(5):596-9. PubMed ID: 15531955
[TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation and homocysteine levels in Behçet's disease.
Mungan AG; Can M; Açikgöz S; Eştürk E; Altinyazar C
Clin Chem Lab Med; 2006; 44(9):1115-8. PubMed ID: 16958606
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
11. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O
Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
[TBL] [Abstract][Full Text] [Related]
12. Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Behçet's disease: is it a new urinary activity marker?
Evereklioglu C; Ozbek E; Cekmen M; Mehmet N; Duygulu F; Ozkiris A; Calip M; Er H; Turkoz Y
Nephrology (Carlton); 2003 Oct; 8(5):231-8. PubMed ID: 15012709
[TBL] [Abstract][Full Text] [Related]
13. Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker?
Evereklioglu C; Turkoz Y; Er H; Inaloz HS; Ozbek E; Cekmen M
J Am Acad Dermatol; 2002 Jan; 46(1):50-4. PubMed ID: 11756945
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D status in Algerian Behçet's disease patients: an immunomodulatory effect on NO pathway.
Djeraba Z; Benlabidi F; Djaballah-Ider FZ; Medjeber O; Arroul-Lammali A; Belguendouz H; Otmani F; Touil-Boukoffa C
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):243-250. PubMed ID: 28532201
[TBL] [Abstract][Full Text] [Related]
15. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
16. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
[TBL] [Abstract][Full Text] [Related]
17. Lectin-like oxidised LDL receptor-1 as a marker of endothelial dysfunction in Behçet's disease.
Ozyazgan S; Uzun H; Onal B; Tuzcu A; Ugurlu S; Andican G
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):71-6. PubMed ID: 24064019
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease.
Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N
Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734
[TBL] [Abstract][Full Text] [Related]
19. The association of inflammatory markers and echocardiographic parameters in Behçet's disease.
Çalık AN; Özcan KS; Mesci B; Çınar T; Çanga Y; Güngör B; Kavala M; Oğuz A; Bolca O; Kozan Ö
Acta Cardiol; 2020 Apr; 75(2):130-137. PubMed ID: 30689956
[No Abstract] [Full Text] [Related]
20. Relationship between serum homocysteine levels and structural-functional carotid arterial abnormalities in inactive Behçet's disease.
Ozdemir R; Yagmur J; Acikgoz N; Cansel M; Karincaoglu Y; Ermis N; Pekdemir H; Arslan AK
Kardiol Pol; 2018; 76(2):413-417. PubMed ID: 29192953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
